Kindeva Drug Delivery

DCAT Week 2025 was one to remember — and this year, we made our presence known in more ways than one. From meaningful meetings to spontaneous street sightings, our Kindeva cars sparked conversations all across New York City. ?? We connected with partners, caught up with familiar faces, and had the privilege of sharing what makes Kindeva different. It was amazing to see the industry come together, and we’re proud to be part of shaping what’s next in drug delivery. To everyone who stopped to say hello, snapped a photo, or joined us for a conversation — thank you. ?? Missed us at DCAT Week? There’s still time to connect: https://loom.ly/d1_7BRk #DCATWeek2025 #KindevaCars #DrugDelivery

How do we design the next generation of drug delivery devices with sustainability in mind? ?? On April 1, Edward Jackson, our Product & Device Development Group Leader, will join industry peers for a live IPAC-RS roundtable: Designing for a Sustainable Future. This complimentary session brings together experts from across the drug-device ecosystem to explore strategies like reusability, circularity, and materials innovation—driving change across the product lifecycle. With sustainability becoming a central focus for pharma and medtech, now is the time to align innovation with environmental responsibility. Don’t miss the chance to gain insights from leaders shaping the future of sustainable drug delivery. ?? Register here: https://lnkd.in/eP4wib2K #IPACrs #PharmaSustainability #DrugDelivery ?? Joining Edward on the panel are: Philip Smith, Principal Engineer, Vectura Group, Glenn Svedberg, Vice President Business Development, Nolato, Alan Harris, Chief Technical Officer, Bespak, Shaun Williams, Product Engineering Manager, Bespak, Mauro Citterio, Director, R&D and Industrialization, Plastiape S.p.A., a Berry Global company

We're proud to announce a new strategic partnership with SHL Medical to expand manufacturing and final assembly services for the Molly? autoinjector platform. ?? This collaboration brings together SHL’s industry-leading drug delivery technology with Kindeva’s expertise in fill finish and combination product development. By integrating these capabilities at Bridgeton and Maryland Heights facilities, this partnership will help pharma and biotech companies streamline production, accelerate timelines, and scale manufacturing to meet global demand. With a shared commitment to advancing patient access and pharmaceutical innovation, this partnership ensures efficient, high-quality manufacturing, bringing life-changing therapies to market faster. Learn more about this partnership and how it enhances self-injection therapy development and delivery here. ?? https://loom.ly/vPemHqw #DrugDelivery #Autoinjectors #PharmaInnovation

What's next for drug development in 2025? Our Chief Commercial Officer, David Stevens, reveals all! From sustainability to advanced manufacturing, the industry is evolving in exciting ways: ?? Get ready for sustainability to take center stage ?? Expect to see greater investment in injectable drug manufacturing ?? Anticipate the rise of more strategic CDMOs We’re here to help you navigate these trends and move your projects forward. Discover how we can support your drug development needs here. ?? https://loom.ly/yOsWdvw #DrugManufacturing #CDMO #SterileInjectables

It’s been a week since DCAT Week 2025 wrapped up, and we’re still reflecting on the insightful conversations, valuable connections, and industry trends that shaped the event. Our key takeaways from the week? ?? The industry is evolving fast - scalability, efficiency, and precision in fill finish are more critical than ever. ?? Innovation is driving change - from advanced combination product solutions to next-gen aseptic manufacturing technologies. ?? Strong partnerships matter - because bringing life-changing treatments to patients starts with working together. A huge thank you to everyone who met with us, joined the discussions, or even spotted our Kindeva Kars around New York! If we didn’t connect at DCAT, let’s keep the conversation going - our team is always here to discuss how we can support your next big breakthrough. Get in touch with us here: ?? https://loom.ly/d1_7BRk #DCATWeek #CDMO #FillFinish

Next week we're heading to the Deployed Medical & Healthcare Delivery conference in London! ?? Join the Kindeva team as we showcase how our trusted drug delivery solutions and proven approach in medical countermeasures can enhance emergency and deployed healthcare worldwide. If you’re ready to collaborate with us to advance healthcare delivery in challenging environments, schedule a meeting with us now and discover how we can transform tomorrow together. Schedule a meeting with us ahead of the event ?? https://loom.ly/jiY1DGU #GlobalHealthSecurity #DrugDelivery #CDMO

As DCAT Week 2025 wraps up, we want to thank everyone who took the time to meet with us, share insights, and discuss the future of pharmaceutical manufacturing and drug delivery innovation. This week has been all about connection, collaboration, and care - values that drive everything we do. Didn’t get a chance to meet with us? It’s not too late to connect! Our team is still available to discuss how Kindeva’s expertise in Fill & Finish, combination products, and advanced manufacturing can help bring your innovations to life. Reach out to our team here: ?? https://loom.ly/d1_7BRk #DCATWeek #CDMO #DrugDevelopment

With Day 3 underway, the energy in New York City is all about meaningful connections and forward-thinking collaborations. If you haven't met with us yet, there's still time to explore how Kindeva can support your drug development and manufacturing needs: ?? Explore industry-leading fill finish expertise – See how our scalable solutions for vials, cartridges, and syringes can support your needs. ?? Discover cutting-edge combination product innovation – From inhalation to transdermal delivery, we optimize drug-device solutions for seamless integration. ?? Learn about our latest high-volume manufacturing capabilities – Our advanced Groninger & Optima lines boost precision, sterility, and efficiency. ?? Connect with a CDMO that truly cares – Experience our “Kind As Ever” approach to collaboration and customer partnership. DCAT is all about connecting with the right partners to move your projects forward. Find us in rooms 412 & 461 in the InterContinental New York Barclay and let’s make it happen! Schedule a meeting here: ?? https://loom.ly/d1_7BRk #DCATWeek #CDMO #PharmaceuticalManufacturing

Kindeva will be in New York City for INTERPHEX Global 2025 in just two weeks. ?? We’ll be connecting with industry partners to discuss how our expertise in inhalation, injectable, and transdermal solutions - can help accelerate pharmaceutical programs from concept to commercialization. Our Vice President of Analytical and Development Services, Jennifer Riter will be giving a presentation titled “Essential Drug Delivery Output Is the New Essential Performance Requirement.” Don’t miss it if you’re looking for key recommendations on combination product compliance, including identifying and gathering data related to Essential Drug Delivery Outputs (EDDOs). And to discover how our comprehensive analytical support can help you at every stage of your journey to market, meet the Kindeva team at booth 3809. Schedule a meeting with us in advance here. ?? https://loom.ly/J6Css7o #CDMO #AnalyticalDevelopment #DrugDevelopment

Next week, our team will be attending the CBRNe Summit Europe 2025 in Oslo, Norway! As a leader in medical countermeasure development, Kindeva is committed to advancing global health security through innovative pharmaceutical solutions. Our global health security experts will be discussing the current CBRNe threats across Europe and highlighting our cutting-edge technologies and emergency response capabilities. Ready to explore how advanced drug delivery can enhance global health security? Schedule a meeting with our team before the event. ?? https://lnkd.in/epWGQZHG #GlobalHealthSecurity #HealthSecurity #CDMO